Multicenter Phase II Trial of NRICM102 Combined With Standard Therapy in Pneumonia

NCT07583992 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

Mild to Moderate
Community-Acquired Pneumonia (CAP)
Antibiotic Therapy
Intravenous
Hospitalisation

Interventions

DRUG: NRICM102
DRUG: Placebo
DRUG: Intravenous Antibiotic

Sponsor

National Research Institute of Chinese Medicine, Ministry of Health and Welfare

Collaborators

[object Object]